TEK2day FINANCE About TEK2day Finance

STIMCELL ENERGETICS INC. (STME)

OQB · Healthcare · Medical Devices

$0.28 +0.00%

Closing price as of 2026-07-28 · Source: TEK2day Finance

1-Year Price History -7.1% over period
$0$0$0$0$0 2026-052026-052026-062026-072026-07

Key Metrics

Market Cap
$5.8M
Shares Outstanding
21.1M
Exchange
OQB
Currency
USD

About STIMCELL ENERGETICS INC.

StimCell Energetics Inc., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions in the United States. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company also develops eBalance Home and eBalance Pro System for temporary relief of shoulder, waist, back, neck, arms, and legs. The company was formerly known as Cell MedX Corp. and changed its name to StimCell Energetics Inc. in November 2024. StimCell Energetics Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.

Quarterly Financials

Metric2025-02-282025-05-312025-11-302026-02-28
Revenue0.000.000.000.00
Operating Income-90K-262K-271K-102K
Net Income-141K-219K-310K-91K
Diluted EPS$-0.01$nan$-0.01$0.00

Annual Financials

Metric2022-05-312023-05-312024-05-312025-05-31
Revenue6K3K0.000.00
Gross Profit4K483.000.00
Operating Income-672K-448K-261K-505K
Net Income-697K-495K-142K-566K
Diluted EPS$-0.15$-0.15$-0.01$-0.03
Want live quotes, estimates, SEC filings, and CEO analytics for STME?
The free TEK2day terminal runs in your browser — type /STME to get started.
Open STME in the Terminal →